05-14-2012, 04:28 PM
Alzheimers Prevention Research to Target Group With Rare Form
A team of researchers will soon try out an experimental drug that could prevent Alzheimers disease in a group of people who have a genetic mutation that makes it likely they will develop the debilitating disease.
Scientists will begin a clinical trial of crenezumab in about 300 Colombians whose genes predispose them to a rare form of Alzheimers that hits very early usually in the 40s or 50s and can affect multiple members of the same family. Funding for the study has been provided by the National Institutes of Health, Genentech and Banner Health System. Genentech is the developer of the experimental drug.
My link
A team of researchers will soon try out an experimental drug that could prevent Alzheimers disease in a group of people who have a genetic mutation that makes it likely they will develop the debilitating disease.
Scientists will begin a clinical trial of crenezumab in about 300 Colombians whose genes predispose them to a rare form of Alzheimers that hits very early usually in the 40s or 50s and can affect multiple members of the same family. Funding for the study has been provided by the National Institutes of Health, Genentech and Banner Health System. Genentech is the developer of the experimental drug.
My link